Cargando…

Formulation and evaluation of an in situ gel-forming ophthalmic formulation of moxifloxacin hydrochloride

BACKGROUND/AIM: The aim of the present investigation is to prepare and evaluate in situ gel-forming ophthalmic drug delivery system of moxifloxacin hydrochloride. MATERIALS AND METHODS: Sodium alginate, a novel ophthalmic gel-forming mucoadhesive polymer, which gets converted to gel in the presence...

Descripción completa

Detalles Bibliográficos
Autores principales: Mandal, Sonjoy, Thimmasetty, Manjunath KMJ, Prabhushankar, GL, Geetha, MS
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3482769/
https://www.ncbi.nlm.nih.gov/pubmed/23119236
http://dx.doi.org/10.4103/2230-973X.100042
_version_ 1782247907299164160
author Mandal, Sonjoy
Thimmasetty, Manjunath KMJ
Prabhushankar, GL
Geetha, MS
author_facet Mandal, Sonjoy
Thimmasetty, Manjunath KMJ
Prabhushankar, GL
Geetha, MS
author_sort Mandal, Sonjoy
collection PubMed
description BACKGROUND/AIM: The aim of the present investigation is to prepare and evaluate in situ gel-forming ophthalmic drug delivery system of moxifloxacin hydrochloride. MATERIALS AND METHODS: Sodium alginate, a novel ophthalmic gel-forming mucoadhesive polymer, which gets converted to gel in the presence of divalent-cations (calcium ion) present in the lachrymal fluid, was used as the gelling agent. Hydroxy propyl methyl cellulose (HPMC) is a mucoadhesive polymer used as viscosity enhancer. Suitable concentrations of buffering agents were used to adjust the pH to 6.5. All the formulations were sterilized in an autoclave at 121°C for 15 minutes. The formulations were evaluated for clarity, pH measurement, gelling capacity, drug content estimation, rheological study, in vitro diffusion study, antibacterial activity, isotonicity, and eye irritation study. RESULTS: The developed formulations exhibited sustained release of drug from formulation over a period of 10 hours thus increasing residence time of the drug. The optimized formulations were tested for eye irritation on albino rabbit (male). The formulations were found to be non-irritating with no ocular damage or abnormal clinical signs to the cornea, iris or conjunctiva observed. CONCLUSION: These in situ gelling systems containing gums may be a valuable alternative to the conventional systems.
format Online
Article
Text
id pubmed-3482769
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-34827692012-11-01 Formulation and evaluation of an in situ gel-forming ophthalmic formulation of moxifloxacin hydrochloride Mandal, Sonjoy Thimmasetty, Manjunath KMJ Prabhushankar, GL Geetha, MS Int J Pharm Investig Original Research Article BACKGROUND/AIM: The aim of the present investigation is to prepare and evaluate in situ gel-forming ophthalmic drug delivery system of moxifloxacin hydrochloride. MATERIALS AND METHODS: Sodium alginate, a novel ophthalmic gel-forming mucoadhesive polymer, which gets converted to gel in the presence of divalent-cations (calcium ion) present in the lachrymal fluid, was used as the gelling agent. Hydroxy propyl methyl cellulose (HPMC) is a mucoadhesive polymer used as viscosity enhancer. Suitable concentrations of buffering agents were used to adjust the pH to 6.5. All the formulations were sterilized in an autoclave at 121°C for 15 minutes. The formulations were evaluated for clarity, pH measurement, gelling capacity, drug content estimation, rheological study, in vitro diffusion study, antibacterial activity, isotonicity, and eye irritation study. RESULTS: The developed formulations exhibited sustained release of drug from formulation over a period of 10 hours thus increasing residence time of the drug. The optimized formulations were tested for eye irritation on albino rabbit (male). The formulations were found to be non-irritating with no ocular damage or abnormal clinical signs to the cornea, iris or conjunctiva observed. CONCLUSION: These in situ gelling systems containing gums may be a valuable alternative to the conventional systems. Medknow Publications & Media Pvt Ltd 2012 /pmc/articles/PMC3482769/ /pubmed/23119236 http://dx.doi.org/10.4103/2230-973X.100042 Text en Copyright: © International Journal of Pharmaceutical Investigation http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research Article
Mandal, Sonjoy
Thimmasetty, Manjunath KMJ
Prabhushankar, GL
Geetha, MS
Formulation and evaluation of an in situ gel-forming ophthalmic formulation of moxifloxacin hydrochloride
title Formulation and evaluation of an in situ gel-forming ophthalmic formulation of moxifloxacin hydrochloride
title_full Formulation and evaluation of an in situ gel-forming ophthalmic formulation of moxifloxacin hydrochloride
title_fullStr Formulation and evaluation of an in situ gel-forming ophthalmic formulation of moxifloxacin hydrochloride
title_full_unstemmed Formulation and evaluation of an in situ gel-forming ophthalmic formulation of moxifloxacin hydrochloride
title_short Formulation and evaluation of an in situ gel-forming ophthalmic formulation of moxifloxacin hydrochloride
title_sort formulation and evaluation of an in situ gel-forming ophthalmic formulation of moxifloxacin hydrochloride
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3482769/
https://www.ncbi.nlm.nih.gov/pubmed/23119236
http://dx.doi.org/10.4103/2230-973X.100042
work_keys_str_mv AT mandalsonjoy formulationandevaluationofaninsitugelformingophthalmicformulationofmoxifloxacinhydrochloride
AT thimmasettymanjunathkmj formulationandevaluationofaninsitugelformingophthalmicformulationofmoxifloxacinhydrochloride
AT prabhushankargl formulationandevaluationofaninsitugelformingophthalmicformulationofmoxifloxacinhydrochloride
AT geethams formulationandevaluationofaninsitugelformingophthalmicformulationofmoxifloxacinhydrochloride